These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 32979074)

  • 1. The interaction between metformin and physical activity on postprandial glucose and glucose kinetics: a randomised, clinical trial.
    Pilmark NS; Lyngbæk M; Oberholzer L; Elkjær I; Petersen-Bønding C; Kofoed K; Siebenmann C; Kellenberger K; van Hall G; Abildgaard J; Ellingsgaard H; Lauridsen C; Ried-Larsen M; Pedersen BK; Hansen KB; Karstoft K
    Diabetologia; 2021 Feb; 64(2):397-409. PubMed ID: 32979074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of dapagliflozin, metformin or exercise on glycaemic variability in overweight or obese individuals with prediabetes (the PRE-D Trial): a multi-arm, randomised, controlled trial.
    Færch K; Blond MB; Bruhn L; Amadid H; Vistisen D; Clemmensen KKB; Vainø CTR; Pedersen C; Tvermosegaard M; Dejgaard TF; Karstoft K; Ried-Larsen M; Persson F; Jørgensen ME
    Diabetologia; 2021 Jan; 64(1):42-55. PubMed ID: 33064182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mealtime 50/50 basal + prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre- and postprandial blood glucose levels in patients with type 2 diabetes: a multinational, 24-week, randomized, open-label, parallel-group comparison.
    Robbins DC; Beisswenger PJ; Ceriello A; Goldberg RB; Moses RG; Pagkalos EM; Milicevic Z; Jones CA; Sarwat S; Tan MH
    Clin Ther; 2007 Nov; 29(11):2349-64. PubMed ID: 18158076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of exercise training alone vs a combined exercise and nutritional lifestyle intervention on glucose homeostasis in prediabetic individuals: a randomised controlled trial.
    Slentz CA; Bateman LA; Willis LH; Granville EO; Piner LW; Samsa GP; Setji TL; Muehlbauer MJ; Huffman KM; Bales CW; Kraus WE
    Diabetologia; 2016 Oct; 59(10):2088-98. PubMed ID: 27421729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metformin in women with type 2 diabetes in pregnancy (MiTy): a multicentre, international, randomised, placebo-controlled trial.
    Feig DS; Donovan LE; Zinman B; Sanchez JJ; Asztalos E; Ryan EA; Fantus IG; Hutton E; Armson AB; Lipscombe LL; Simmons D; Barrett JFR; Karanicolas PJ; Tobin S; McIntyre HD; Tian SY; Tomlinson G; Murphy KE;
    Lancet Diabetes Endocrinol; 2020 Oct; 8(10):834-844. PubMed ID: 32946820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of glucagon-like peptide 1 in the postprandial effects of metformin in type 2 diabetes: a randomized crossover trial.
    Hansen LS; Gasbjerg LS; Brønden A; Dalsgaard NB; Bahne E; Stensen S; Hellmann PH; Rehfeld JF; Hartmann B; Wewer Albrechtsen NJ; Holst JJ; Vilsbøll T; Knop FK
    Eur J Endocrinol; 2024 Aug; 191(2):192-203. PubMed ID: 39049802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metformin for the prevention of diabetes among people with HIV and either impaired fasting glucose or impaired glucose tolerance (prediabetes) in Tanzania: a Phase II randomised placebo-controlled trial.
    Garrib A; Kivuyo S; Bates K; Ramaiya K; Wang D; Majaliwa E; Simbauranga R; Charles G; van Widenfelt E; Luo H; Alam U; Nyirenda MJ; Jaffar S; Mfinanga S;
    Diabetologia; 2023 Oct; 66(10):1882-1896. PubMed ID: 37460828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exercise improves metformin 72-h glucose control by reducing the frequency of hyperglycemic peaks.
    Ortega JF; Morales-Palomo F; Ramirez-Jimenez M; Moreno-Cabañas A; Mora-Rodríguez R
    Acta Diabetol; 2020 Jun; 57(6):715-723. PubMed ID: 32020414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A whey/guar "preload" improves postprandial glycaemia and glycated haemoglobin levels in type 2 diabetes: A 12-week, single-blind, randomized, placebo-controlled trial.
    Watson LE; Phillips LK; Wu T; Bound MJ; Checklin HL; Grivell J; Jones KL; Clifton PM; Horowitz M; Rayner CK
    Diabetes Obes Metab; 2019 Apr; 21(4):930-938. PubMed ID: 30520216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exercise training decreases pancreatic fat content and improves beta cell function regardless of baseline glucose tolerance: a randomised controlled trial.
    Heiskanen MA; Motiani KK; Mari A; Saunavaara V; Eskelinen JJ; Virtanen KA; Koivumäki M; Löyttyniemi E; Nuutila P; Kalliokoski KK; Hannukainen JC
    Diabetologia; 2018 Aug; 61(8):1817-1828. PubMed ID: 29717337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of liraglutide for overweight adult patients with type 1 diabetes and insufficient glycaemic control (Lira-1): a randomised, double-blind, placebo-controlled trial.
    Dejgaard TF; Frandsen CS; Hansen TS; Almdal T; Urhammer S; Pedersen-Bjergaard U; Jensen T; Jensen AK; Holst JJ; Tarnow L; Knop FK; Madsbad S; Andersen HU
    Lancet Diabetes Endocrinol; 2016 Mar; 4(3):221-232. PubMed ID: 26656289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exenatide once weekly plus dapagliflozin once daily versus exenatide or dapagliflozin alone in patients with type 2 diabetes inadequately controlled with metformin monotherapy (DURATION-8): a 28 week, multicentre, double-blind, phase 3, randomised controlled trial.
    Frías JP; Guja C; Hardy E; Ahmed A; Dong F; Öhman P; Jabbour SA
    Lancet Diabetes Endocrinol; 2016 Dec; 4(12):1004-1016. PubMed ID: 27651331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integration of a fasting-mimicking diet programme in primary care for type 2 diabetes reduces the need for medication and improves glycaemic control: a 12-month randomised controlled trial.
    van den Burg EL; Schoonakker MP; van Peet PG; van den Akker-van Marle EM; Lamb HJ; Longo VD; Numans ME; Pijl H
    Diabetologia; 2024 Jul; 67(7):1245-1259. PubMed ID: 38546821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of acarbose versus glibenclamide on glycemic excursion and oxidative stress in type 2 diabetic patients inadequately controlled by metformin: a 24-week, randomized, open-label, parallel-group comparison.
    Wang JS; Lin SD; Lee WJ; Su SL; Lee IT; Tu ST; Tseng YH; Lin SY; Sheu WH
    Clin Ther; 2011 Dec; 33(12):1932-42. PubMed ID: 22078152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and Safety of LixiLan, a Titratable Fixed-Ratio Combination of Lixisenatide and Insulin Glargine, Versus Insulin Glargine in Type 2 Diabetes Inadequately Controlled on Metformin Monotherapy: The LixiLan Proof-of-Concept Randomized Trial.
    Rosenstock J; Diamant M; Aroda VR; Silvestre L; Souhami E; Zhou T; Perfetti R; Fonseca V;
    Diabetes Care; 2016 Sep; 39(9):1579-86. PubMed ID: 27284114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of LY3298176, a novel dual GIP and GLP-1 receptor agonist, in patients with type 2 diabetes: a randomised, placebo-controlled and active comparator-controlled phase 2 trial.
    Frias JP; Nauck MA; Van J; Kutner ME; Cui X; Benson C; Urva S; Gimeno RE; Milicevic Z; Robins D; Haupt A
    Lancet; 2018 Nov; 392(10160):2180-2193. PubMed ID: 30293770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chinese herbal medicine for impaired glucose tolerance: a randomized placebo controlled trial.
    Grant SJ; Chang DH; Liu J; Wong V; Kiat H; Bensoussan A
    BMC Complement Altern Med; 2013 May; 13():104. PubMed ID: 23672597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metformin and exercise effects on postprandial insulin sensitivity and glucose kinetics in pre-diabetic and diabetic adults.
    Moreno-Cabañas A; Morales-Palomo F; Alvarez-Jimenez L; Mora-Gonzalez D; Ortega JF; Mora-Rodriguez R
    Am J Physiol Endocrinol Metab; 2023 Oct; 325(4):E310-E324. PubMed ID: 37584610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Withdrawal of medications leads to worsening of OGTT parameters in youth with impaired glucose tolerance or recently-diagnosed type 2 diabetes.
    Hannon TS; Edelstein SL; Arslanian SA; Caprio S; Zeitler PS; Buchanan TA; Ehrmann DA; Mather KJ; Tripputi M; Kahn SE; Nadeau KJ;
    Pediatr Diabetes; 2020 Dec; 21(8):1437-1446. PubMed ID: 32985775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of biphasic insulin aspart 30 given three times daily or twice daily in combination with metformin versus oral antidiabetic drugs alone in patients with poorly controlled type 2 diabetes: a 16-week, randomized, open-label, parallel-group trial conducted in russia.
    Ushakova O; Sokolovskaya V; Morozova A; Valeeva F; Zanozina O; Sazonova O; Zhadanova E; Starceva M; Kazakova E; Saifullina M; Shapiro I; Tarasov A; Al-Tayar B; Starkova N
    Clin Ther; 2007 Nov; 29(11):2374-84. PubMed ID: 18158078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.